A review of ketamine’s role in ECT and non-ECT settings
Vytautas Jankauskas,1 Candace Necyk,2 James Chue,3 Pierre Chue4 1Department of Pharmacy, Grey Nuns Community Hospital, Edmonton, Alberta, Canada; 2Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada; 3Department of Anesthesiology, State University of Ne...
Enregistré dans:
Auteurs principaux: | Jankauskas V, Necyk C, Chue J, Chue P |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fef3a95d03fa475a9a3bb5bb8c34b25b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ventilation Adjustment in ECT During COVID-19: Voluntary Hyperventilation is an Effective Strategy
par: de Arriba-Arnau A, et autres
Publié: (2021) -
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
par: Szarmach J, et autres
Publié: (2020) -
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
par: Wei Zheng, et autres
Publié: (2021) -
Number of Electroconvulsive Therapy Sessions required for Thai Psychiatric Patients: a Retrospective Study
par: Ittasakul P, et autres
Publié: (2020) -
Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT
par: Aksay SS, et autres
Publié: (2014)